跳至主要内容
临床试验/JPRN-jRCT1031210136
JPRN-jRCT1031210136招募中未知

A randomized, open-label, parallel-group study of the efficacy of oral Ninjin'yoeito in improving fatigability and nutritional status in the perioperative period of primary lung cancer - Efficacy of oral Ninjin'yoeito for improvement of fatigability and nutritional status in the perioperative period of primary lung cancer

Ishibashi Hironori0 个研究点目标入组 332 人开始时间: 2021年6月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
332

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 65age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Patients aged 65 years or older who will undergo anatomical lung resection and systematic lymph node dissection for primary lung cancer at our department.
  • 2. Patients who have given written consent for this study.
  • 3. Patients with primary lung cancer in stages 0, I, II and III.

排除标准

  • 1. The patient does not give consent to participate in the study.
  • 2.The patient has a history of allergy to Ninjin'yoeito or its components.
  • 3. The patient has severe anorexia, nausea, or vomiting, which is a cautious administration of the study drug.
  • 4. The patient with severe hepatic or renal dysfunction.

研究者

发起方
Ishibashi Hironori

相似试验